{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:44:46Z","timestamp":1793814286574,"version":"4.6.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jcyt.2021.09.015","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T01:01:07Z","timestamp":1643072467000},"page":"421-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Prevention of chronic diabetic complications in type 1 diabetes by co-transplantation of umbilical cord mesenchymal stromal cells and autologous bone marrow: a pilot randomized controlled open-label clinical study with 8-year follow-up"],"prefix":"10.1016","volume":"24","author":[{"given":"Zhixian","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinquan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0794-3995","authenticated-orcid":false,"given":"Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camillo","family":"Ricordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jcyt.2021.09.015_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/db10-1114","article-title":"Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man","volume":"60","author":"Skyler","year":"2011","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.jcyt.2021.09.015_bib0002","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2337\/diacare.23.4.472","article-title":"The association of diabetes specialist care with health care practices and glycemic control in patients with type 1 diabetes: a cross-sectional analysis from the Pittsburgh epidemiology of diabetes complications study","volume":"23","author":"Zgibor","year":"2000","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jcyt.2021.09.015_bib0003","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2337\/dc15-0171","article-title":"Umbilical Cord Mesenchymal Stromal Cell With Autologous Bone Marrow Cell Transplantation in Established Type 1 Diabetes: A Pilot Randomized Controlled Open-Label Clinical Study to Assess Safety and Impact on Insulin Secretion","volume":"39","author":"Cai","year":"2016","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.jcyt.2021.09.015_bib0004","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jcyt.2015.03.608","article-title":"Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus","volume":"17","author":"Thakkar","year":"2015","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.jcyt.2021.09.015_bib0005","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/bmt.2015.294","article-title":"Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations","volume":"51","author":"Snarski","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jcyt.2021.09.015_bib0006","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/scd.2016.0275","article-title":"Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study","volume":"26","author":"Bhansali","year":"2017","journal-title":"Stem Cells Dev"},{"issue":"1","key":"10.1016\/j.jcyt.2021.09.015_bib0007","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13643-017-0662-9","article-title":"Safety and efficacy of hematopoietic and mesanchymal stem cell therapy for treatment of T1DM: a systematic review and meta-analysis protocol","volume":"7","author":"Madani","year":"2018","journal-title":"Systematic reviews"},{"issue":"Suppl 1","key":"10.1016\/j.jcyt.2021.09.015_bib0008","first-page":"s79","article-title":"Nephropathy in Diabetes","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.jcyt.2021.09.015_bib0009","first-page":"82","article-title":"A review of clinical trials: mesenchymal stem cell transplant therapy in type 1 and type 2 diabetes mellitus","volume":"7","author":"Cho","year":"2018","journal-title":"American journal of stem cells"},{"issue":"Suppl","key":"10.1016\/j.jcyt.2021.09.015_bib0010","first-page":"S67","article-title":"Application of new vascular regenerative therapy using autologous bone marrow cells for intractable cardiovascular diseases","volume":"52","author":"Miyamoto","year":"2003","journal-title":"Masui The Japanese journal of anesthesiology"},{"issue":"7","key":"10.1016\/j.jcyt.2021.09.015_bib0011","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3390\/ijms20071784","article-title":"Empowering Mesenchymal Stem Cells for Ocular Degenerative Disorders","volume":"20","author":"Ding","year":"2019","journal-title":"International journal of molecular sciences"},{"issue":"4","key":"10.1016\/j.jcyt.2021.09.015_bib0012","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1742-1241.2011.02886.x","article-title":"Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients","volume":"66","author":"Kirana","year":"2012","journal-title":"International journal of clinical practice"},{"issue":"12","key":"10.1016\/j.jcyt.2021.09.015_bib0013","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jcyt.2014.08.010","article-title":"Comparison of the effect of stem cell therapy and percutaneous transluminal angioplasty on diabetic foot disease in patients with critical limb ischemia","volume":"16","author":"Dubsky","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2021.09.015_bib0014","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ebiom.2016.09.011","article-title":"Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study","volume":"12","author":"Packham","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jcyt.2021.09.015_bib0015","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.12659\/MSM.914860","article-title":"Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor beta (TGF-beta)\/smad Pathway and Pro-Inflammatory Cytokines","volume":"25","author":"Bai","year":"2019","journal-title":"Medical science monitor: international medical journal of experimental and clinical research"},{"issue":"5","key":"10.1016\/j.jcyt.2021.09.015_bib0016","first-page":"2629","article-title":"Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment","volume":"41","author":"Li","year":"2018","journal-title":"International journal of molecular medicine"},{"issue":"1","key":"10.1016\/j.jcyt.2021.09.015_bib0017","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13287-017-0542-1","article-title":"Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus","volume":"8","author":"Ye","year":"2017","journal-title":"Stem cell research & therapy"},{"issue":"2","key":"10.1016\/j.jcyt.2021.09.015_bib0018","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2337\/db14-0656","article-title":"Preserved beta-cell function in type 1 diabetes by mesenchymal stromal cells","volume":"64","author":"Carlsson","year":"2015","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.jcyt.2021.09.015_bib0019","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2337\/dc14-2830","article-title":"Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study","volume":"38","author":"Skyler","year":"2015","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jcyt.2021.09.015_bib0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1507\/endocrj.EJ12-0343","article-title":"Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus","volume":"60","author":"Hu","year":"2013","journal-title":"Endocr J"},{"issue":"11","key":"10.1016\/j.jcyt.2021.09.015_bib0021","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s00125-005-1949-2","article-title":"Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?","volume":"48","author":"Meier","year":"2005","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.jcyt.2021.09.015_bib0022","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2009.21","article-title":"The role of inflammation in insulitis and beta-cell loss in type 1 diabetes","volume":"5","author":"Eizirik","year":"2009","journal-title":"Nature reviews Endocrinology"},{"issue":"7","key":"10.1016\/j.jcyt.2021.09.015_bib0023","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1517\/14712598.2011.574119","article-title":"Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions","volume":"11","author":"Wang","year":"2011","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"10.1016\/j.jcyt.2021.09.015_bib0024","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1172\/JCI200316502","article-title":"In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion","volume":"111","author":"Ianus","year":"2003","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.jcyt.2021.09.015_bib0025","first-page":"686","article-title":"Complications Trial \/Epidemiology of Diabetes I, Complications Study Research G (2016) Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT\/EDIC Study 30-Year Follow-up","volume":"39","author":"Diabetes","year":"2021","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jcyt.2021.09.015_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2841","article-title":"Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis","volume":"33","author":"Papadopoulou-Marketou","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"10.1016\/j.jcyt.2021.09.015_bib0027","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nm0603-702","article-title":"Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration","volume":"9","author":"Rafii","year":"2003","journal-title":"Nature medicine"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324921008252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324921008252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:45:59Z","timestamp":1761443159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324921008252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1465324921008252"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2021.09.015","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of chronic diabetic complications in type 1 diabetes by co-transplantation of umbilical cord mesenchymal stromal cells and autologous bone marrow: a pilot randomized controlled open-label clinical study with 8-year follow-up","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2021.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of International Society for Cell & Gene Therapy.","name":"copyright","label":"Copyright"}]}}